| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Regulatory Officer
1 company
Raj K. Puri is Chief Regulatory Officer at IOVA. Raj K. Puri's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.3M at current prices.
Net of sales, the IOVA filings show accumulation of 5,600 shares.
Raj K. Puri has 16 Form 4 filings on record from December 2024 to September 2026, all as Chief Regulatory Officer at Iovance Biotherapeutics (IOVA), 2024–2026.
The 28 reported transactions were 12 option exercises, 12 tax withholdings, 3 option or other derivative awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $10K and no sales.
The only open-market purchase was 5,600 shares of IOVA at an average $1.74 on May 23, 2025, about $10K. Twelve months later IOVA was up 131%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 23, 2025 | IOVA Iovance Biotherapeutics, Inc. | Chief Regulatory Officer | Buy | 5,600 | $1.74 | $9,743.44 | +2.8% | +42.7% | +130.9% |